Advertisement

Search Results for "gilead-sciences"

Forbes List Logo
Switching sciences: Pharma billionaires
Can India's pharma giants, who rose on the strength of chemistry, soar on the back of biology?
ByHarichandan Arakali
Eris Life Sciences: Drug Money
BySeema Singh
Strand Life Sciences: Bringing Genetic Tests To The Average Customer
ByDebojyoti Ghosh
Prashant Kumar Pathak's Delcure Life Sciences is just a milestone for him
ByBrand Connect
AI and the social sciences used to talk more. Now they've drifted apart.
ByKellogg School of Management
AI and the social sciences used to talk more. Now they've drifted apart
ByKellogg School of Management
US Tax Cuts and Jobs Act: Ind AS accounting implications on Life Sciences companies
ByJigar Parikh
WHO Rejects Antiviral Drug Remdesivir as a Covid-19 Treatment
Gilead's COVID-19 Drug is Mediocre. It Will Be a Blockbuster Anyway

Latest News

Photo of the day: India Art Fair kicks off in Delhi
ByForbes India
RBI likely to hold interest rates in February 6 policy meet
BySalil Panchal
Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
India’s concert economy: Booming sales, lagging infrastructure
ByNaini Thaker,Himani Kothari
AI agents form their own social network, humans left fascinated and alarmed
ByNaini Thaker
Advertisement
Advertisement

On Everyone’s Radar

Advertisement